Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

Shares of vaccine-maker Moderna (MRNA) closed at $34.71 on Monday, close to their 52-week low of$29.25.Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales performance of its recently launched RSV vaccine. There have also been several third-party reports that the U.S. government is re-evaluating the $590 million contract that was recently awarded to the company for the development of an mRNA-based vaccine for bird flu.In the past year, MRNA stock has lost two-thi ...